245 filings
Page 2 of 13
8-K
w6wd0yiau0eijdo7t52
4 Aug 22
Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
6:07am
8-K
u908ylus9sh
15 Jul 22
Departure of Directors or Certain Officers
6:11am
8-K
c4dsy6s
20 May 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
g4l90d1
10 May 22
Aurinia Reports First Quarter 2022 Financial and Operational Results
6:06am
8-K
lkdzm znv9cchmoej0yh
28 Feb 22
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
6:08am
8-K/A
39v8ae
7 Jan 22
CLINICAL PROGRAM UPDATE AURORA 2 / voclosporin Updated January 2022
4:10pm
8-K
868zb0j
9 Dec 21
Regulation FD Disclosure
6:31am
8-K
nsgoqj8ky4e5 ubz8w
3 Nov 21
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
12:00am
8-K/A
wr9lzjn
17 Sep 21
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
mvqp9872tta2b1uabit
17 Aug 21
Riptide Aurinia Collaboration & License Agreement
4:07pm
8-K
0uangd15g6d5ocv7l205
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:12pm
8-K
ckm68v lwom
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:11pm
8-K
p8zh2dgfs
19 Jul 21
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
12:00am
8-K
ztumqxre3dg3vro 0i
25 Jun 21
Regulation FD Disclosure
4:12pm
8-K
uqc g1gu05xy6gx
17 Jun 21
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
4:36pm
8-K
muiyo40 06t35fc6
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
8-K
tob8z i2n4w
6 May 21
Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights
4:08pm
8-K
h653 ah1g3mmpt
27 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:17pm
8-K
p6xkvy75178l zbeh2dc
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
8-K
y7pr1e
25 Jan 21
Financial Statements and Exhibits
8:21am